论文信息 - Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study - 字舞流文

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study

M. Grever | M. Knopp | B. Ramaswamy | C. Shapiro | A. Chen | J. Sparano | W. Duan | M. Villalona-Calero | S. Gillespie | S. Geyer | J. Chalmers | N. Hall | A. Shoben | E. Andreopoulou | B. Miller | Jun Zhang | C. Wright | M. Lustberg | P. Balasubramanian | Michael Berger | R. Wesolowski | R. Layman | E. Mrózek | D. Stover | P. Amaya | Meng Zhao | E. Macrae | Alahdra Carey | Peter Amaya